By
Dr Salihi Abdulmalik
National Orthopaedic Hospital Dala-Kano
19th February, 2021
Outline
• Introduction
• Classifications
• Properties of bone graft
• Indications
• Graft incorporation
• Principles
• Bone graft substitute
• Complications
• Conclusion
Introduction
• Bone graft/substitute can be defined as
any material that alone or in combination
with other materials promotes bone
healing by providing osteogenic,
osteoinduction and osteoconductive
activity to the local site
• BG is among the most commonly
transplanted tissue in the body
 Based on vascularity
◦ Vascularised
 Theoretically the ideal graft
 Microsurgical skills needed
 Sources;
 Iliac crest with one of the circumference a. e.g PCIA
 Fibula with peroneal artery
 Ribs with posterior intercoastal artery
◦ Non-vascularised
 Fibular strut
Classification
• Based on source
– Autograft (gold standard)
– Allograft
– Isograft
– Xenograft
– BG substitute
 Autograft
◦ No immunogenicity
◦ No disease transmission
◦ Cheap
◦ Limited availability
◦ Donor site morbidity
◦ Increased op and anaesthetic time
 Allograft
◦ No donor site morbidity
◦ Large amounts available
◦ Disease transmission
◦ Immunogenic
◦ Slow incorporation
◦ Bone banking
Based on composition
◦ Cancellous
– More rapidly incorporated
– Sources – iliac crest, GT, metaphysis of proximal
tibia, distal femur, distal tibia, distal radius,
proximal humerus
◦ Cortical
– Less biologically active
– Less surface area
– Less cellular matrix
– Prolong time to revascularize
– They may need fixation
– Sources – iliac crest, fibula, ribs, anterior-medial
surface of tibia
◦ Corticocancellous
– Dual function of providing healing and
support
– Sources – iliac crest and tibia plateau
◦ Osteochondral
◦ Bone marrow aspirate
 Richer and more
growth factors
 Up to 50cc of bone
graft can be
harvested
 Based on state of graft
◦ Fresh
 Highly antigenic
 Limited time to check antigenicity
◦ Preserved using
 Ethylene oxide
 Ionizing radiation
 Freezing (-70 degree)
 Freeze drying
 Demineralization
 Osteoconduction
◦ Provide scaffold/matrix for which new bone will be
laid down
 Osteoinduction
◦ Provide growth factors that encourage
differentiation of messenchymal cells into
osteoblast
 Osteogenic
◦ Presence of cells that related to bone formation
such as primitive messenchymal cells, osteoblast
and osteocytes
 Augment fracture healing e.g non union
 Fill defect e.g following cyst or tumour
excision
 Arthrodesis
 To replace a bone/disc
 Establish continuity of long bone e.g fibula
strut
 Aid screw fixation in osteoporotic bone
 Help establish union in pseudoarthrosis
 Provide joint block to limit joint motion
(arthroereisis)
 Treatment of bone gap e.g Masquelet
technique
 Metabolic bone diseases
 Presence of infection in Allograft
 Autograft undergo necrosis
 Viable surface cells on the graft stimulate
inflammatory response
 Fibrovascular stroma formed
 Blood vessels and osteoprogenitor cells pass
from recipient bone to graft
 Remaining viable cells stimulate
osteoprogenitor cells which differentiate to
osteoblast (osteoinduction)
 Graft also provide scaffold for new bone
(osteoconduction)
 New bone formed replaced graft (creeping
substitution)
 Cancellous bone incorporate more quickly
and complete
 Vascularised graft remain viable
 Cancellous
◦ Faster
◦ Analogous to fracture healing
◦ Creeping substitution
 Cortical
◦ Slower inflammatory process
◦ Osteoclastic activity precede osteoblastic bone
formation
◦ Loss of mechanical strength first 3-6 months,
returns over 1-2 years
 Entire graft not incorporated
 No remodelling
 Inflammation; chemotaxis stimulated by
necrotic debris
 Osteoblast differentiation from precursors
 Osteoinduction; osteoblast and osteoclast
 Osteoconduction
 Remodelling process continues for years

 Local (+v)
◦ Large surface area
◦ Good vascular supply
◦ Growth factors; BMP, VEGF, PDGF
◦ Mechanical loading
◦ Mechanical stability
 Local (-ve)
◦ Denervation
◦ Infection
◦ Radiation
◦ Local bone disease
◦ Foreign body
◦ Mechanical instabilty
 Systemic (+ve)
◦ Growth hormone
◦ Insulin
◦ PTH
◦ Thyroid hormone
◦ Vitamins A and D
 Systemic (-ve)
◦ DM
◦ Steroid
◦ Chemo
◦ Malnutrition
◦ NSAIDS
◦ Metabolic bone disease
◦ Sepsis
◦ Smoking
 Pre op
◦ Indications met
◦ Remove/reduce –ve factors
◦ Informed consent
 Intra op
◦ GA/SAB, positioning, exposure
◦ Fresh instruments/gloves for op and donor site
◦ Cortical window
◦ Stay posterior to ASIS
◦ Don’t go beyond 8cm lateral to PSIS
 In children posterior iliac crest is a good donor site
◦ Dissect directly down to the bone
◦ Expose only area needed
◦ Take only amount needed
◦ Cancellous BG; morselisation increases the surface
area of the graft and also exposes the bone cells
◦ Harvested bone graft should be kept moist
◦ Achieve haemostasis
 Post op
◦ Monitor post op bleeding
◦ Analgesia
◦ Protect donor site
◦ Change dressing as frequent as necessary
 Dispensable?
◦ Dispose and harvest another graft
 Indispensable?
◦ Rinse with normal saline
◦ Place in antibiotics for 10-15 minutes
◦ Make use of the graft
◦ Inform patient post op
 Bleeding
 Nerve injury
 Vascular injury
 Pathological fracture
 Hernia
 Urethral injury
 ASIS avulsion
 Pelvic instability
 BMP
◦ Originally extracted from allogenic BG
◦ BMP 2 and 7 are commercially produced
◦ Need carriers
 Allograft
 Demineralized bone matrix
 Collagen
 Bone cement
 Calcium based
 Calcium phosphate
 Calcium hydroxyapetite
 Calcium sulphate
◦ Primarily osteoconductive
◦ Calcium hydroxyapetite and phosphate are used to
fill metaphyseal defects
 Tibial plateau
 Calcaneum
 Radial fracture
◦ No sufficient strength
◦ Absorbed
 Calcium sulphate 6-9 weeks
 Calcium phosphate 6-9 months
 Calcium hydroxyapetite several years
 Bone graft and bone graft substitute play
important role in orthopaedics; arthroplasty,
limb reconstruction, spine etc

Bone graft

  • 1.
    By Dr Salihi Abdulmalik NationalOrthopaedic Hospital Dala-Kano 19th February, 2021
  • 2.
    Outline • Introduction • Classifications •Properties of bone graft • Indications • Graft incorporation • Principles • Bone graft substitute • Complications • Conclusion
  • 3.
    Introduction • Bone graft/substitutecan be defined as any material that alone or in combination with other materials promotes bone healing by providing osteogenic, osteoinduction and osteoconductive activity to the local site • BG is among the most commonly transplanted tissue in the body
  • 4.
     Based onvascularity ◦ Vascularised  Theoretically the ideal graft  Microsurgical skills needed  Sources;  Iliac crest with one of the circumference a. e.g PCIA  Fibula with peroneal artery  Ribs with posterior intercoastal artery ◦ Non-vascularised  Fibular strut
  • 5.
    Classification • Based onsource – Autograft (gold standard) – Allograft – Isograft – Xenograft – BG substitute
  • 6.
     Autograft ◦ Noimmunogenicity ◦ No disease transmission ◦ Cheap ◦ Limited availability ◦ Donor site morbidity ◦ Increased op and anaesthetic time
  • 7.
     Allograft ◦ Nodonor site morbidity ◦ Large amounts available ◦ Disease transmission ◦ Immunogenic ◦ Slow incorporation ◦ Bone banking
  • 8.
    Based on composition ◦Cancellous – More rapidly incorporated – Sources – iliac crest, GT, metaphysis of proximal tibia, distal femur, distal tibia, distal radius, proximal humerus ◦ Cortical – Less biologically active – Less surface area – Less cellular matrix – Prolong time to revascularize – They may need fixation – Sources – iliac crest, fibula, ribs, anterior-medial surface of tibia
  • 9.
    ◦ Corticocancellous – Dualfunction of providing healing and support – Sources – iliac crest and tibia plateau ◦ Osteochondral ◦ Bone marrow aspirate
  • 10.
     Richer andmore growth factors  Up to 50cc of bone graft can be harvested
  • 11.
     Based onstate of graft ◦ Fresh  Highly antigenic  Limited time to check antigenicity ◦ Preserved using  Ethylene oxide  Ionizing radiation  Freezing (-70 degree)  Freeze drying  Demineralization
  • 12.
     Osteoconduction ◦ Providescaffold/matrix for which new bone will be laid down  Osteoinduction ◦ Provide growth factors that encourage differentiation of messenchymal cells into osteoblast  Osteogenic ◦ Presence of cells that related to bone formation such as primitive messenchymal cells, osteoblast and osteocytes
  • 13.
     Augment fracturehealing e.g non union  Fill defect e.g following cyst or tumour excision  Arthrodesis  To replace a bone/disc  Establish continuity of long bone e.g fibula strut
  • 14.
     Aid screwfixation in osteoporotic bone  Help establish union in pseudoarthrosis  Provide joint block to limit joint motion (arthroereisis)  Treatment of bone gap e.g Masquelet technique
  • 15.
     Metabolic bonediseases  Presence of infection in Allograft
  • 16.
     Autograft undergonecrosis  Viable surface cells on the graft stimulate inflammatory response  Fibrovascular stroma formed  Blood vessels and osteoprogenitor cells pass from recipient bone to graft  Remaining viable cells stimulate osteoprogenitor cells which differentiate to osteoblast (osteoinduction)
  • 17.
     Graft alsoprovide scaffold for new bone (osteoconduction)  New bone formed replaced graft (creeping substitution)  Cancellous bone incorporate more quickly and complete  Vascularised graft remain viable
  • 18.
     Cancellous ◦ Faster ◦Analogous to fracture healing ◦ Creeping substitution  Cortical ◦ Slower inflammatory process ◦ Osteoclastic activity precede osteoblastic bone formation ◦ Loss of mechanical strength first 3-6 months, returns over 1-2 years
  • 19.
     Entire graftnot incorporated  No remodelling
  • 20.
     Inflammation; chemotaxisstimulated by necrotic debris  Osteoblast differentiation from precursors  Osteoinduction; osteoblast and osteoclast  Osteoconduction  Remodelling process continues for years 
  • 21.
     Local (+v) ◦Large surface area ◦ Good vascular supply ◦ Growth factors; BMP, VEGF, PDGF ◦ Mechanical loading ◦ Mechanical stability
  • 22.
     Local (-ve) ◦Denervation ◦ Infection ◦ Radiation ◦ Local bone disease ◦ Foreign body ◦ Mechanical instabilty
  • 23.
     Systemic (+ve) ◦Growth hormone ◦ Insulin ◦ PTH ◦ Thyroid hormone ◦ Vitamins A and D
  • 24.
     Systemic (-ve) ◦DM ◦ Steroid ◦ Chemo ◦ Malnutrition ◦ NSAIDS ◦ Metabolic bone disease ◦ Sepsis ◦ Smoking
  • 25.
     Pre op ◦Indications met ◦ Remove/reduce –ve factors ◦ Informed consent
  • 26.
     Intra op ◦GA/SAB, positioning, exposure ◦ Fresh instruments/gloves for op and donor site ◦ Cortical window ◦ Stay posterior to ASIS ◦ Don’t go beyond 8cm lateral to PSIS  In children posterior iliac crest is a good donor site ◦ Dissect directly down to the bone
  • 27.
    ◦ Expose onlyarea needed ◦ Take only amount needed ◦ Cancellous BG; morselisation increases the surface area of the graft and also exposes the bone cells ◦ Harvested bone graft should be kept moist ◦ Achieve haemostasis
  • 28.
     Post op ◦Monitor post op bleeding ◦ Analgesia ◦ Protect donor site ◦ Change dressing as frequent as necessary
  • 29.
     Dispensable? ◦ Disposeand harvest another graft  Indispensable? ◦ Rinse with normal saline ◦ Place in antibiotics for 10-15 minutes ◦ Make use of the graft ◦ Inform patient post op
  • 30.
     Bleeding  Nerveinjury  Vascular injury  Pathological fracture  Hernia  Urethral injury  ASIS avulsion  Pelvic instability
  • 31.
     BMP ◦ Originallyextracted from allogenic BG ◦ BMP 2 and 7 are commercially produced ◦ Need carriers  Allograft  Demineralized bone matrix  Collagen  Bone cement
  • 32.
     Calcium based Calcium phosphate  Calcium hydroxyapetite  Calcium sulphate ◦ Primarily osteoconductive ◦ Calcium hydroxyapetite and phosphate are used to fill metaphyseal defects  Tibial plateau  Calcaneum  Radial fracture ◦ No sufficient strength
  • 33.
    ◦ Absorbed  Calciumsulphate 6-9 weeks  Calcium phosphate 6-9 months  Calcium hydroxyapetite several years
  • 34.
     Bone graftand bone graft substitute play important role in orthopaedics; arthroplasty, limb reconstruction, spine etc